Main Highlights 1. Syringe maker Catalent suggested soaring demand for injectable weight-loss drugs could lead to sizable revenue gains, and shares surged. 2. The company said sales of its pre-filled syringes could increase more than five-fold because of the popularity of those drugs. 3. Catalent also released preliminary quarterly results, and revenue exceeded...
Analyzing the options chain and the chart patterns of CTLT Catalent prior to the earnings report this week, I would consider purchasing the 40usd strike price in the money Calls with an expiration date of 2024-1-19, for a premium of approximately $8.30. If these options prove to be profitable prior to the earnings release, I would sell at least half of...
Price on this daily chart is currently within a down channel. However price is close to the bottom of the down channel. I expect a W like recovery from this bottom, which shows with the bars pattern tool in green. Similar down periods in green lines also.
Catalent - 30d expiry - We look to Sell a break of 65.98 (stop at 69.98) We have a Gap open at 6.2. from 56.05 to 69.46. The primary trend remains bearish. A break of support at 66.44 should lead to a more aggressive move lower towards 55.00. This stock has seen poor sales growth. Our outlook is bearish. Our profit targets will be 55.98 and 53.98...
CTLT looking bullish after a double bottom right on the 200 EMA. Also has a nice MACD pattern. Will buy now or keep a close eye on it for a retracement bar to use for an entry.
It is pulling back after failed broke out and forming a handle.
RSI broke below the trend. If it gets down $47.15, double top forms
Here is another good looking stock. I like the way the Moving averages all converged then a nice pop above all of them. I'm in this one, think it will run.